PHI 32/24 Consultation on draft Cost Recovery Implementation Statement (CRIS)

For administration of the Prescribed List of Medical Devices and Human Tissue Products between 1 July 2024 to 30 June 2025

Date published:
PHI circular type:
Prostheses announcement
Audience:
Health sector

Stakeholders are invited to provide feedback on the draft Cost Recovery Implementation Statement (CRIS) 1 July 2024 – 30 June 2025 for Administration of the Prescribed List of Benefits for Medical Devices and Human Tissue Products (the Prescribed List).

This draft CRIS provides information on how the department will administer cost recovery arrangements relating to the Prescribed List for the 2024-25 financial year.

The draft CRIS also provides information on financial and non-financial performance, legislative changes, and financial and demand forecasts for 2024-2025 and three forward years.

The CRIS was last updated on 30 November 2023 to report the financial and non-financial results for the 2022-23 financial year.

Stakeholders can submit their feedback to PLcostrecovery@Health.gov.au by 29 May 2024.

The final CRIS document will include a summary of the feedback received from stakeholders.